A MICRA sponsored reports paints a bright future for the Midlands-based businesses and showcases opportunities for investment
ChromaTwist Ltd – a spinout from MICRA partner the University of Birmingham – has secured £300k of seed funding to develop a new class of fluorescent materials for use in bio-sensing and bio-imaging tests for diseases such as cancer and diabetes.
Previsico – a fast growing insurance technology spinout from MICRA partner Lougborough University – have announced a new partnership with major insurer Zurich.
University of Nottingham linked PBD Biotech has secured a £2.3m investment to take Actiphage through to validation by the World Organisation for Animal Health (OIE). Full validation will enable international adoption of this novel, patented, diagnostic for mycobacterial diseases, which include human tuberculosis and Johne’s Disease.